AzTrials
AzTrials

Health BehaviorPHEWNCT05686889

Post-Hoc Enthusiasm and Wariness

A study testing Patient self-report in people with Health Behavior, run by Sunnybrook Health Sciences Centre.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The post-hoc fallacy (also termed the post-hoc-ergo-propter-hoc fallacy) has been recognized for centuries with endless relevance. The general concept in medical care is that patients who improve after a treatment are not necessary patients who improve because of a treatment. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Health Behavior
What is being tested?
Patient self-report
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
No sites listed yet
Study dates
1 May 2023to 1 Sep 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Community pharmacist

Who cannot join

  • Outside Ontario

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Donald A Redelmeier, MD, MSc contact

4164806999

dar@ices.on.ca

About this study

The post-hoc fallacy (also termed the post-hoc-ergo-propter-hoc fallacy) has been recognized for centuries with endless relevance. The general concept in medical care is that patients who improve after a treatment are not necessary patients who improve because of a treatment. Modern medicine provides multiple opportunities to examine such pitfalls of judgment due to the prevailing uncertainty, incompleteness of our understanding pathogenic mechanisms, and natural tendency to connect treatments to outcomes. In this study, we will investigate whether judgments about vitamin supplementation might demonstrate the post-hoc fallacy.

Read the detailed description

We plan to conduct a brief survey of pharmacies portraying a patient in two slightly different versions. One version will portray the patient who feels better after starting a vitamin supplement whereas another version will portray the patient who feels unchanged after starting a vitamin supplement. The patients will be randomly assigned to participants and otherwise contain identical information. Judgments will be measured by eliciting participants recommendation about continuing the vitamin (Appendix_Script).

Conditions
Health Behavior
Being tested
Patient self-report
Medical subject headings
Health Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Patient self-reportOther

    Simulated patient following structured script

Study groups in NCT05686889
Study groupRoleWhat they receive
SuccessExperimentalSymptomatic improvement present
Receives: Other: Patient self-report
FailureExperimentalSymptomatic improvement absent
Receives: Other: Patient self-report

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Response variable in each survey is a binary recommendation whether to continue the vitamin supplement or discontinue the vitamin supplement

    Health provider clinical recommendation

    Measured: Short-term (less than 5 minutes)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jan 2023
  2. Study start1 May 2023 (estimated)
  3. Primary completion1 Sep 2023 (estimated)
  4. Study completion1 Sep 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05686889
Sponsor's protocol ID
5692
Acronym
PHEW
Status last verified
Jan 2023
First submitted
7 Jan 2023
Last updated
17 Jan 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Patient self-report in people with Health Behavior, run by Sunnybrook Health Sciences Centre.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 17 Jan 2023. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Donald A Redelmeier, MD, MSc (4164806999, dar@ices.on.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Response variable in each survey is a binary recommendation whether to continue the vitamin supplement or discontinue the vitamin supplement (time frame: Short-term (less than 5 minutes)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jan 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in